Primary intestinal pseudo-obstruction and Bradycardia

Summary:

Bradycardia is found among people with Primary intestinal pseudo-obstruction, especially for people who are male, 60+ old.

The study analyzes which people have Bradycardia with Primary intestinal pseudo-obstruction. It is created by eHealthMe based on reports of 20 people who have Primary intestinal pseudo-obstruction from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Primary intestinal pseudo-obstruction?

Primary intestinal pseudo-obstruction (symptoms of intestinal blockage without any physical signs of a blockage) is found to be associated with 100 drugs and 563 conditions by eHealthMe. Check the latest studies of Primary intestinal pseudo-obstruction.

What is Bradycardia?

Bradycardia (abnormally slow heart action) is found to be associated with 1,930 drugs and 3,118 conditions by eHealthMe. Check the latest studies of Bradycardia.

On Jul, 13, 2026

20 people who have Primary Intestinal Pseudo-Obstruction and Bradycardia are studied.

Would you have Bradycardia when you have Primary intestinal pseudo-obstruction?

Gender of people who have Primary Intestinal Pseudo-Obstruction and experienced Bradycardia *:

female: 5.26 %
male: 94.74 %

Age of people who have Primary Intestinal Pseudo-Obstruction and experienced Bradycardia *:

Common co-existing conditions for these people *:

Pain: 12 people, 60.00%
Sedation: 11 people, 55.00%
Constipation: 6 people, 30.00%
Extubation: 3 people, 15.00%
Laxative Supportive Care: 1 person, 5.00%
Hypokalemia (low potassium): 1 person, 5.00%
Diarrhea: 1 person, 5.00%
Cryptosporidiosis Infection (an intestinal disease caused by the cryptosporidium parasite): 1 person, 5.00%
Abdominal Discomfort: 1 person, 5.00%

Common drugs taken by these people *:

Common symptoms for these people *:

Hypotension (abnormally low blood pressure): 17 people, 85.00%
Cardiac Arrest: 16 people, 80.00%
Drug Ineffective: 3 people, 15.00%
Haemodynamic Instability (disturbances in the blood movement in our body): 2 people, 10.00%
Pulseless Electrical Activity: 1 person, 5.00%
Drug Hypersensitivity: 1 person, 5.00%
Dizziness: 1 person, 5.00%
Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 1 person, 5.00%
Arrhythmias (irregular heartbeat): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Bradycardia?

- Check whether Bradycardia is associated with a drug or a condition

Related publications that referenced our studies

Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
Oflaz MB, Kucukdurmaz Z, Guven AS, Karapinar H, Kaya A, Sancakdar E, Deveci K, Gul I, Erdem A, Cevit O, Icagasioglu FD, "Bradycardia seen in children with Crimean-Congo hemorrhagic fever", Vector-Borne and Zoonotic Diseases, 2013 Nov .
Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
Oflaz MB, Kucukdurmaz Z, Guven AS, Karapinar H, Kaya A, Sancakdar E, Deveci K, Gul I, Erdem A, Cevit O, Icagasioglu FD, "Bradycardia seen in children with Crimean-Congo hemorrhagic fever", Vector-Borne and Zoonotic Diseases, 2013 Nov .

Related studies:

Treatments, associated drugs and conditions:

Primary intestinal pseudo-obstruction (1,159 reports)
Bradycardia (61,180 reports)

All the drugs that are associated with Bradycardia:

Bradycardia (1,930 drugs)

All the conditions that are associated with Bradycardia:

Bradycardia (3,118 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Bradycardia and Primary intestinal pseudo-obstruction, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.